Strata Critical Medical (SRTA) Operating Expenses (2019 - 2026)

Strata Critical Medical (SRTA) has 8 years of Operating Expenses data on file, last reported at $17.1 million in Q1 2026.

• Quarterly Operating Expenses rose 34.17% year-over-year to $17.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $64.9 million (up 6.38% YoY) and the FY2025 annual result came in at $63.5 million, up 21.81% from the prior year.
• Operating Expenses advanced to $17.1 million in Q1 2026 per SRTA's latest filing, from -$82.8 million in the prior quarter.
• Across five years, Operating Expenses topped out at $83.1 million in Q4 2023 and bottomed at -$82.8 million in Q4 2025.
• The 5-year median for Operating Expenses is $54.9 million (2025), against an average of $30.9 million.
• The widest annual swing landed in 2023, when Operating Expenses soared 1003.57%; it then plunged 190.16% in 2024.
• Tracing SRTA's Operating Expenses over 5 years: stood at -$8.1 million in 2022, then jumped by 1125.94% to $83.1 million in 2023, then sank by 190.16% to -$74.9 million in 2024, then retreated by 10.52% to -$82.8 million in 2025, then soared by 120.64% to $17.1 million in 2026.
• Per Business Quant, the three latest SRTA Operating Expenses figures stand at $17.1 million (Q1 2026), -$82.8 million (Q4 2025), and $54.9 million (Q3 2025).

Peer Comparison